Treatment of Hypertrophic Lichen Planus

First-Line Treatment Approach

The British Journal of Dermatology recommends advising avoidance of all irritants and fragranced products that may exacerbate the condition 2
Treatment should be continued until symptoms improve and hyperkeratosis resolves, typically over 2-3 months, followed by a gradual taper to avoid rebound flares, as suggested by Praxis Medical Insights 1

The British Journal of Dermatology suggests beginning with a potent topical corticosteroid such as clobetasol propionate 0.05% or mometasone furoate applied once daily for 4 weeks 3, 4
After initial improvement, reduce frequency to alternate days for 4 weeks, then twice weekly for another 4 weeks, as recommended by the British Journal of Dermatology 3
The British Journal of Dermatology advises explaining to parents/caregivers the proper amount to use (fingertip unit method) and safe application technique to minimize side effects 2
A 30g tube should last approximately 12 weeks when used appropriately, according to the British Journal of Dermatology 3

The British Journal of Dermatology recommends scheduling follow-up at 3 months to assess treatment response and ensure proper medication use 5
If good response is achieved, schedule another assessment 6 months later to ensure continued improvement before considering discharge, as suggested by the British Journal of Dermatology 5
Monitor for potential side effects of prolonged topical steroid use, though studies have shown that this regimen is generally safe in children when used appropriately, according to the British Journal of Dermatology 3

The British Journal of Dermatology suggests considering referral to a specialist dermatology clinic if inadequate response after 3 months of appropriate topical steroid therapy 2
For resistant hypertrophic lesions, intralesional triamcinolone (10-20 mg) may be considered after excluding malignancy by biopsy, as recommended by the British Journal of Dermatology 2
Other second-line options for refractory cases include narrow-band UVB phototherapy or oral antihistamines for pruritus control, according to Praxis Medical Insights 1

Biopsy may be necessary in atypical or treatment-resistant cases to confirm diagnosis and exclude other conditions, as suggested by the British Journal of Dermatology 5